![BDA BDA](https://data.pdbj.org/pdbjplus/data/cc/svg/BDA.svg) | BDA | 表記: | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | 組成式: | C62 H66 N2 O20 | SMILES: | O=C2c1c(O)c%11c(c(O)c1C(=O)c3cccc(OC)c23)CC(O)(C(=O)C)CC%11OC4OC(C)C(O)C(C4)[NH2+]Cc5ccc(cc5)C[NH2+]C%10C(O)C(OC(OC9c8c(O)c7C(=O)c6c(OC)cccc6C(=O)c7c(O)c8CC(O)(C(=O)C)C9)C%10)C | InChi: | InChI=1S/C62H64N2O20/c1-25-51(67)35(17-41(81-25)83-39-21-61(77,27(3)65)19-33-45(39)59(75)49-47(55(33)71)53(69)31-9-7-11-37(79-5)43(31)57(49)73)63-23-29-13-15-30(16-14-29)24-64-36-18-42(82-26(2)52(36)68)84-40-22-62(78,28(4)66)20-34-46(40)60(76)50-48(56(34)72)54(70)32-10-8-12-38(80-6)44(32)58(50)74/h7-16,25-26,35-36,39-42,51-52,63-64,67-68,71-72,75-78H,17-24H2,1-6H3/p+2/t25-,26-,35-,36-,39-,40-,41-,42-,51+,52+,61-,62-/m0/s1 | 別名: | WP631 | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S,3S,4S,6R,2'S,3'S,4'S,6'R)-N,N'-(benzene-1,4-diyldimethanediyl)bis(6-{[(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl]oxy}-3-hydroxy-2-methyltetrahydro-2H-pyran-4-aminium) (non-preferred name) |
|
![BDC BDC](https://data.pdbj.org/pdbjplus/data/cc/svg/BDC.svg) | BDC | 表記: | BIS-(9-OCTYLAMINO(2-DIMETHYLAMINOETHYL)ACRIDINE-4-CARBOXAMIDE | 組成式: | C44 H54 N8 O2 | SMILES: | O=C(NCCN(C)C)c3c2nc1c(cccc1)c(c2ccc3)NCCCCCCCCNc4c6c(nc5c4cccc5C(=O)NCCN(C)C)cccc6 | InChi: | InChI=1S/C44H54N8O2/c1-51(2)29-27-47-43(53)35-21-15-19-33-39(31-17-9-11-23-37(31)49-41(33)35)45-25-13-7-5-6-8-14-26-46-40-32-18-10-12-24-38(32)50-42-34(40)20-16-22-36(42)44(54)48-28-30-52(3)4/h9-12,15-24H,5-8,13-14,25-30H2,1-4H3,(H,45,49)(H,46,50)(H,47,53)(H,48,54) | 別名: | BIS-DACA | 定義日: | 2001-10-12 | 最終更新日: | 2021-03-01 | 識別子(ID): | 9,9'-(octane-1,8-diyldiimino)bis{N-[2-(dimethylamino)ethyl]acridine-4-carboxamide} |
|
![BE6 BE6](https://data.pdbj.org/pdbjplus/data/cc/svg/BE6.svg) | BE6 | 表記: | (2R,3R,4R,5R)-2,5-BIS[(2,5-DIFLUOROBENZYL)OXY]-3,4-DIHYDROXY-N,N'-BIS[(1S,2R)-2-HYDROXY-2,3-DIHYDRO-1H-INDEN-1-YL]HEXANEDIAMIDE | 組成式: | C38 H36 F4 N2 O8 | SMILES: | Fc1cc(c(F)cc1)COC(C(=O)NC3c2ccccc2CC3O)C(O)C(O)C(OCc4cc(F)ccc4F)C(=O)NC6c5ccccc5CC6O | InChi: | InChI=1S/C38H36F4N2O8/c39-23-9-11-27(41)21(13-23)17-51-35(37(49)43-31-25-7-3-1-5-19(25)15-29(31)45)33(47)34(48)36(52-18-22-14-24(40)10-12-28(22)42)38(50)44-32-26-8-4-2-6-20(26)16-30(32)46/h1-14,29-36,45-48H,15-18H2,(H,43,49)(H,44,50)/t29-,30-,31+,32+,33-,34-,35-,36-/m1/s1 | 別名: | HIV-1 INHIBITOR | 定義日: | 2004-08-10 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R,3R,4R,5R)-2,5-bis[(2,5-difluorobenzyl)oxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide (non-preferred name) |
|
![BEA BEA](https://data.pdbj.org/pdbjplus/data/cc/svg/BEA.svg) | BEA | 表記: | 5-METHYL-1,2,4-TRIAZOLO[3,4-B]BENZOTHIAZOLE | 組成式: | C9 H8 N3 S | SMILES: | n2[nH+]c3sc1c(c(ccc1)C)n3c2 | InChi: | InChI=1S/C9H7N3S/c1-6-3-2-4-7-8(6)12-5-10-11-9(12)13-7/h2-5H,1H3/p+1 | 別名: | TRICYCLAZOLE | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | 5-methyl[1,2,4]triazolo[3,4-b][1,3]benzothiazol-1-ium |
|
![BEE BEE](https://data.pdbj.org/pdbjplus/data/cc/svg/BEE.svg) | BEE | 表記: | N,N-[2,5-O-[DI-4-THIOPHEN-3-YL-BENZYL]-GLUCARYL]-DI-[VALYL-AMIDO-METHANE] | 組成式: | C40 H50 N4 O8 S2 | SMILES: | O=C(NC)C(NC(=O)C(OCc2ccc(c1ccsc1)cc2)C(O)C(O)C(OCc4ccc(c3ccsc3)cc4)C(=O)NC(C(=O)NC)C(C)C)C(C)C | InChi: | InChI=1S/C40H50N4O8S2/c1-23(2)31(37(47)41-5)43-39(49)35(51-19-25-7-11-27(12-8-25)29-15-17-53-21-29)33(45)34(46)36(40(50)44-32(24(3)4)38(48)42-6)52-20-26-9-13-28(14-10-26)30-16-18-54-22-30/h7-18,21-24,31-36,45-46H,19-20H2,1-6H3,(H,41,47)(H,42,48)(H,43,49)(H,44,50)/t31-,32-,33+,34+,35+,36+/m0/s1 | 別名: | INHIBITOR BEA409 | 定義日: | 2000-01-31 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(methylcarbamoyl)propyl]-2,5-bis[(4-thiophen-3-ylbenzyl)oxy]hexanediamide (non-preferred name) |
|
![BEG BEG](https://data.pdbj.org/pdbjplus/data/cc/svg/BEG.svg) | BEG | 表記: | 2,5-DIBENZYLOXY-3-HYDROXY-HEXANEDIOIC ACID BIS-[(2-HYDROXY-INDAN-1-YL)-AMIDE] | 組成式: | C38 H40 N2 O7 | SMILES: | O=C(NC2c1ccccc1CC2O)C(OCc3ccccc3)CC(O)C(OCc4ccccc4)C(=O)NC6c5ccccc5CC6O | InChi: | InChI=1S/C38H40N2O7/c41-30-19-26-15-7-9-17-28(26)34(30)39-37(44)33(46-22-24-11-3-1-4-12-24)21-32(43)36(47-23-25-13-5-2-6-14-25)38(45)40-35-29-18-10-8-16-27(29)20-31(35)42/h1-18,30-36,41-43H,19-23H2,(H,39,44)(H,40,45)/t30-,31-,32-,33-,34+,35+,36-/m1/s1 | 別名: | INHIBITOR BEA425 | 定義日: | 1999-10-05 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R,3R,5R)-2,5-bis(benzyloxy)-3-hydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide (non-preferred name) |
|
![BEI BEI](https://data.pdbj.org/pdbjplus/data/cc/svg/BEI.svg) | BEI | 表記: | N,N-[2,5-O-[DIBENZYL]-GLUCARYL]-DI-[ISOLEUCYL-AMIDO-METHANE] | 組成式: | C34 H50 N4 O8 | SMILES: | O=C(NC)C(NC(=O)C(OCc1ccccc1)C(O)C(O)C(OCc2ccccc2)C(=O)NC(C(=O)NC)C(C)CC)C(C)CC | InChi: | InChI=1S/C34H50N4O8/c1-7-21(3)25(31(41)35-5)37-33(43)29(45-19-23-15-11-9-12-16-23)27(39)28(40)30(46-20-24-17-13-10-14-18-24)34(44)38-26(22(4)8-2)32(42)36-6/h9-18,21-22,25-30,39-40H,7-8,19-20H2,1-6H3,(H,35,41)(H,36,42)(H,37,43)(H,38,44)/t21-,22-,25-,26-,27+,28+,29+,30+/m0/s1 | 別名: | INHIBITOR BEA322 | 定義日: | 2000-01-31 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R,3R,4R,5R)-2,5-bis(benzyloxy)-3,4-dihydroxy-N,N'-bis[(1S,2S)-2-methyl-1-(methylcarbamoyl)butyl]hexanediamide (non-preferred name) |
|
![PL7 PL7](https://data.pdbj.org/pdbjplus/data/cc/svg/PL7.svg) | PL7 | 表記: | (2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID | 組成式: | C16 H18 N2 O9 | SMILES: | O=C(O)CCC(=NOCC(C(=O)O)NC(=O)COc1ccccc1)/C(=O)O | InChi: | InChI=1S/C16H18N2O9/c19-13(9-26-10-4-2-1-3-5-10)17-12(16(24)25)8-27-18-11(15(22)23)6-7-14(20)21/h1-5,12H,6-9H2,(H,17,19)(H,20,21)(H,22,23)(H,24,25)/b18-11+/t12-/m0/s1 | 別名: | PHENYLACETYL LACTIVICIN | 定義日: | 2006-12-23 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2E)-2-({(2S)-2-carboxy-2-[(phenoxyacetyl)amino]ethoxy}imino)pentanedioic acid |
|
![BEU BEU](https://data.pdbj.org/pdbjplus/data/cc/svg/BEU.svg) | BEU | 表記: | N-[(1S,2R,5R,6R)-2-AMINO-5,6-DIHYDROXY-4-(HYDROXYMETHYL)CYCLOHEX-3-EN-1-YL]ACETAMIDE | 組成式: | C9 H16 N2 O4 | SMILES: | O=C(NC1C(C=C(C(O)C1O)CO)N)C | InChi: | InChI=1S/C9H16N2O4/c1-4(13)11-7-6(10)2-5(3-12)8(14)9(7)15/h2,6-9,12,14-15H,3,10H2,1H3,(H,11,13)/t6-,7+,8-,9-/m1/s1 | 別名: | 2-ACETYLAMINO-2-DEOXY-1-EPIVALIENAMINE | 定義日: | 2007-07-03 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-[(1S,2R,5R,6R)-2-amino-5,6-dihydroxy-4-(hydroxymethyl)cyclohex-3-en-1-yl]acetamide |
|
![PL9 PL9](https://data.pdbj.org/pdbjplus/data/cc/svg/PL9.svg) | PL9 | 表記: | 2,3-DIMETHYL-5-(3,7,11,15,19,23,27,31,35-NONAMETHYL-2,6,10,14,18,22,26,30,34-HEXATRIACONTANONAENYL-2,5-CYCLOHEXADIENE-1,4-DIONE-2,3-DIMETHYL-5-SOLANESYL-1,4-BENZOQUINONE | 組成式: | C53 H80 O2 | SMILES: | O=C1C(=CC(=O)C(=C1C)C)CC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)C | InChi: | InChI=1S/C53H80O2/c1-40(2)21-13-22-41(3)23-14-24-42(4)25-15-26-43(5)27-16-28-44(6)29-17-30-45(7)31-18-32-46(8)33-19-34-47(9)35-20-36-48(10)37-38-51-39-52(54)49(11)50(12)53(51)55/h21,23,25,27,29,31,33,35,37,39H,13-20,22,24,26,28,30,32,34,36,38H2,1-12H3 | 別名: | PLASTOQUINONE 9 | 定義日: | 2001-06-25 | 最終更新日: | 2021-03-01 | 識別子(ID): | 2,3-dimethyl-5-(3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-yl)cyclohexa-2,5-diene-1,4-dione |
|
![PLB PLB](https://data.pdbj.org/pdbjplus/data/cc/svg/PLB.svg) | PLB | 表記: | 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID | 組成式: | C18 H11 Cl2 N3 O4 | SMILES: | Clc1ccc(c(Cl)c1)C(=O)Nc3c(C(=O)O)cc(Oc2ncccn2)cc3 | InChi: | InChI=1S/C18H11Cl2N3O4/c19-10-2-4-12(14(20)8-10)16(24)23-15-5-3-11(9-13(15)17(25)26)27-18-21-6-1-7-22-18/h1-9H,(H,23,24)(H,25,26) | 別名: | 5-(2-PYRIMIDINYLOXY)-2-BENZOYLAMINOBENZOIC ACID | 定義日: | 2004-08-24 | 最終更新日: | 2021-03-01 | 識別子(ID): | 2-{[(2,4-dichlorophenyl)carbonyl]amino}-5-(pyrimidin-2-yloxy)benzoic acid |
|
![PLG PLG](https://data.pdbj.org/pdbjplus/data/cc/svg/PLG.svg) | PLG | 表記: | N-GLYCINE-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YL-METHANE] | 組成式: | C10 H15 N2 O7 P | SMILES: | O=P(O)(O)OCc1cnc(c(O)c1CNCC(=O)O)C | InChi: | InChI=1S/C10H15N2O7P/c1-6-10(15)8(3-11-4-9(13)14)7(2-12-6)5-19-20(16,17)18/h2,11,15H,3-5H2,1H3,(H,13,14)(H2,16,17,18) | 別名: | N-PYRIDOXYL-GLYCINE-5-MONOPHOSPHATE | 定義日: | 1999-12-01 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)glycine |
|
![PLO PLO](https://data.pdbj.org/pdbjplus/data/cc/svg/PLO.svg) | PLO | 表記: | (3BETA)-3-HYDROXYPREGN-5-EN-20-ONE | 組成式: | C21 H32 O2 | SMILES: | O=C(C)C2C1(CCC3C(C1CC2)CC=C4C3(CCC(O)C4)C)C | InChi: | InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1 | 別名: | PREGNENOLONE | 定義日: | 2003-07-31 | 最終更新日: | 2021-03-01 | 識別子(ID): | (3alpha,8alpha)-3-hydroxypregn-5-en-20-one |
|
![PLP PLP](https://data.pdbj.org/pdbjplus/data/cc/svg/PLP.svg) | PLP | 表記: | PYRIDOXAL-5'-PHOSPHATE | 組成式: | C8 H10 N O6 P | SMILES: | O=P(O)(O)OCc1cnc(c(O)c1C=O)C | InChi: | InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14) | 別名: | VITAMIN B6 Phosphate | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate |
|
![PLR PLR](https://data.pdbj.org/pdbjplus/data/cc/svg/PLR.svg) | PLR | 表記: | (5-HYDROXY-4,6-DIMETHYLPYRIDIN-3-YL)METHYL DIHYDROGEN PHOSPHATE | 組成式: | C8 H12 N O5 P | SMILES: | O=P(O)(O)OCc1cnc(c(O)c1C)C | InChi: | InChI=1S/C8H12NO5P/c1-5-7(4-14-15(11,12)13)3-9-6(2)8(5)10/h3,10H,4H2,1-2H3,(H2,11,12,13) | 別名: | 4'-DEOXYPYRIDOXINE PHOSPHATE | 定義日: | 2003-07-03 | 最終更新日: | 2021-03-01 | 識別子(ID): | (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl dihydrogen phosphate |
|
![PLV PLV](https://data.pdbj.org/pdbjplus/data/cc/svg/PLV.svg) | PLV | 表記: | N-({3-HYDROXY-2-METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN-4-YL}METHYL)-O-METHYL-L-SERINE | 組成式: | C12 H19 N2 O8 P | SMILES: | O=C(O)C(NCc1c(cnc(c1O)C)COP(=O)(O)O)COC | InChi: | InChI=1S/C12H19N2O8P/c1-7-11(15)9(4-14-10(6-21-2)12(16)17)8(3-13-7)5-22-23(18,19)20/h3,10,14-15H,4-6H2,1-2H3,(H,16,17)(H2,18,19,20)/t10-/m0/s1 | 別名: | PYRIDOXYL-(O-METHYL-SERINE)-5-MONOPHOSPHATE | 定義日: | 2003-07-15 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-O-methyl-L-serine |
|
![BFQ BFQ](https://data.pdbj.org/pdbjplus/data/cc/svg/BFQ.svg) | BFQ | 表記: | IBANDRONATE | 組成式: | C9 H23 N O7 P2 | SMILES: | O=P(O)(O)C(O)(CCN(CCCCC)C)P(=O)(O)O | InChi: | InChI=1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17) | 別名: | [1-HYDROXY-3-(METHYL-PENTYL-AMINO)-1-PHOSPHONO-PROPYL]-PHOSPHONIC ACID | 定義日: | 2006-01-11 | 最終更新日: | 2021-03-01 | 識別子(ID): | {1-hydroxy-3-[methyl(pentyl)amino]propane-1,1-diyl}bis(phosphonic acid) |
|
![BFU BFU](https://data.pdbj.org/pdbjplus/data/cc/svg/BFU.svg) | BFU | 表記: | 1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA | 組成式: | C18 H17 Br F N3 O3 | SMILES: | O=C(Nc1ncc(Br)cc1)NC3CC3c2c(F)ccc(C(=O)CC)c2O | InChi: | InChI=1S/C18H17BrFN3O3/c1-2-14(24)10-4-5-12(20)16(17(10)25)11-7-13(11)22-18(26)23-15-6-3-9(19)8-21-15/h3-6,8,11,13,25H,2,7H2,1H3,(H2,21,22,23,26)/t11-,13+/m1/s1 | 別名: | MSC204 | 定義日: | 2000-02-10 | 最終更新日: | 2021-03-01 | 識別子(ID): | 1-(5-bromopyridin-2-yl)-3-[(1S,2S)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea |
|
![PM7 PM7](https://data.pdbj.org/pdbjplus/data/cc/svg/PM7.svg) | PM7 | 表記: | (5aS,12aS,13aS)-12,12-dimethyl-2,3,11,12,12a,13-hexahydro-1H,5H,6H-5a,13a-(epiminomethano)indolizino[7,6-b]carbazol-14-one | 組成式: | C21 H25 N3 O | SMILES: | N2C(=O)C61CCCN1CC23C(C(c5c(C3)c4c(cccc4)n5)(C)C)C6 | InChi: | InChI=1S/C21H25N3O/c1-19(2)16-11-21-8-5-9-24(21)12-20(16,23-18(21)25)10-14-13-6-3-4-7-15(13)22-17(14)19/h3-4,6-7,16,22H,5,8-12H2,1-2H3,(H,23,25)/t16-,20+,21-/m0/s1 | 別名: | premalbrancheamide E | 定義日: | 2017-07-17 | 最終更新日: | 2021-03-01 | 公開日: | 2017-08-16 | 識別子(ID): | (5aS,12aS,13aS)-12,12-dimethyl-2,3,11,12,12a,13-hexahydro-1H,5H,6H-5a,13a-(epiminomethano)indolizino[7,6-b]carbazol-14-one |
|
![BGD BGD](https://data.pdbj.org/pdbjplus/data/cc/svg/BGD.svg) | BGD | 表記: | N-BENZOYL-L-GLUTAMYL-[4-PHOSPHONO(DIFLUOROMETHYL)]-L-PHENYLALANINE-[4-PHOSPHONO(DIFLUORO-METHYL)]-L-PHENYLALANINEAMIDE | 組成式: | C32 H34 F4 N4 O12 P2 | SMILES: | FC(F)(c1ccc(cc1)CC(C(=O)N)NC(=O)C(NC(=O)C(NC(=O)c2ccccc2)CCC(=O)O)Cc3ccc(cc3)C(F)(F)P(=O)(O)O)P(=O)(O)O | InChi: | InChI=1S/C32H34F4N4O12P2/c33-31(34,53(47,48)49)21-10-6-18(7-11-21)16-24(27(37)43)39-30(46)25(17-19-8-12-22(13-9-19)32(35,36)54(50,51)52)40-29(45)23(14-15-26(41)42)38-28(44)20-4-2-1-3-5-20/h1-13,23-25H,14-17H2,(H2,37,43)(H,38,44)(H,39,46)(H,40,45)(H,41,42)(H2,47,48,49)(H2,50,51,52)/t23-,24-,25-/m0/s1 | 別名: | 4-BENZOYLAMINO-4-{1-{1-CARBAMOYL-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-2-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-ETHYLCARBAMOYL}-BUTYRIC ACID | 定義日: | 2002-05-16 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-(phenylcarbonyl)-L-alpha-glutamyl-4-[difluoro(phosphono)methyl]-L-phenylalanyl-4-[difluoro(phosphono)methyl]-L-phenylalaninamide |
|
![PMT PMT](https://data.pdbj.org/pdbjplus/data/cc/svg/PMT.svg) | PMT | 表記: | PHOSPHORIC ACID MONO-[3-(3-{[5-(4-AMINO-2-OXO-2H-PYRIMIDIN-1-YL)-3,4- DIHYDROXY-TETRAHYDRO-FURAN-2- YLMETHOXY]-HYDROXY-PHOSPHORYLOXY}-3-OXO-PROPYLCARBAMOYL)-3-HYDROXY-2,2- DIMETHYL-PROPYL] ESTER | 組成式: | C18 H30 N4 O15 P2 | SMILES: | O=P(O)(O)OCC(C)(C)C(O)C(=O)NCCC(=O)OP(=O)(O)OCC2OC(N1C(=O)N=C(N)C=C1)C(O)C2O | InChi: | InChI=1S/C18H30N4O15P2/c1-18(2,8-35-38(29,30)31)14(26)15(27)20-5-3-11(23)37-39(32,33)34-7-9-12(24)13(25)16(36-9)22-6-4-10(19)21-17(22)28/h4,6,9,12-14,16,24-26H,3,5,7-8H2,1-2H3,(H,20,27)(H,32,33)(H2,19,21,28)(H2,29,30,31)/t9-,12-,13-,14+,16-/m1/s1 | 別名: | 4'-PHOSPHOPANTOTHENOYL- CYTIDINE-5'-MONOPHOSPHATE | 定義日: | 2004-08-06 | 最終更新日: | 2021-03-01 | 識別子(ID): | 5'-O-{(S)-hydroxy[(3-{[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]amino}propanoyl)oxy]phosphoryl}cytidine |
|
![PMV PMV](https://data.pdbj.org/pdbjplus/data/cc/svg/PMV.svg) | PMV | 表記: | (3R)-3-HYDROXY-3-METHYL-5-(PHOSPHONOOXY)PENTANOIC ACID | 組成式: | C6 H13 O7 P | SMILES: | O=P(O)(O)OCCC(O)(C)CC(=O)O | InChi: | InChI=1S/C6H13O7P/c1-6(9,4-5(7)8)2-3-13-14(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H2,10,11,12)/t6-/m1/s1 | 別名: | PHOSPHOMEVALONATE | 定義日: | 2007-04-30 | 最終更新日: | 2021-03-01 | 識別子(ID): | (3R)-3-hydroxy-3-methyl-5-(phosphonooxy)pentanoic acid |
|
![BGT BGT](https://data.pdbj.org/pdbjplus/data/cc/svg/BGT.svg) | BGT | 表記: | TERT-BUTYL D-ALPHA-GLUTAMINATE | 組成式: | C9 H18 N2 O3 | SMILES: | O=C(OC(C)(C)C)C(N)CCC(=O)N | InChi: | InChI=1S/C9H18N2O3/c1-9(2,3)14-8(13)6(10)4-5-7(11)12/h6H,4-5,10H2,1-3H3,(H2,11,12)/t6-/m0/s1 | 別名: | GLUTAMINE T-BUTYL ESTER | 定義日: | 2005-07-29 | 最終更新日: | 2021-03-01 | 識別子(ID): | tert-butyl L-glutaminate |
|
![BGU BGU](https://data.pdbj.org/pdbjplus/data/cc/svg/BGU.svg) | BGU | 表記: | 2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one | 組成式: | C9 H8 N6 O | SMILES: | O=C1c3c(N=C(N1)N)cc2nc(N)nc2c3 | InChi: | InChI=1S/C9H8N6O/c10-8-13-5-1-3-4(2-6(5)14-8)12-9(11)15-7(3)16/h1-2H,(H3,10,13,14)(H3,11,12,15,16) | 別名: | 2-Amino-lin-Benzogunaine | 定義日: | 2007-08-28 | 最終更新日: | 2021-03-01 | 識別子(ID): | 2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one |
|
![BGV BGV](https://data.pdbj.org/pdbjplus/data/cc/svg/BGV.svg) | BGV | 表記: | (3aR,4S,4aR,7aR,8R,9aS)-4a,8-dimethyl-3-methylidene-2,5-dioxo-2,3,3a,4,4a,5,7a,8,9,9a-decahydroazuleno[6,5-b]furan-4-yl acetate | 組成式: | C17 H20 O5 | SMILES: | O=C1C=CC2C(CC3OC(=O)C(=C)C3C(OC(=O)C)C12C)C | InChi: | InChI=1S/C17H20O5/c1-8-7-12-14(9(2)16(20)22-12)15(21-10(3)18)17(4)11(8)5-6-13(17)19/h5-6,8,11-12,14-15H,2,7H2,1,3-4H3/t8-,11+,12+,14-,15+,17+/m1/s1 | 別名: | bigelovin | 定義日: | 2010-10-07 | 最終更新日: | 2021-03-01 | 識別子(ID): | (3aR,4S,4aR,7aR,8R,9aS)-4a,8-dimethyl-3-methylidene-2,5-dioxo-2,3,3a,4,4a,5,7a,8,9,9a-decahydroazuleno[6,5-b]furan-4-yl acetate |
|